| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |